Literature DB >> 2022066

The treatment of hypercalcaemia of malignancy.

D Heath1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2022066     DOI： 10.1111/j.1365-2265.1991.tb00286.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  4 in total

1.  Hypercalcaemia: changing causes over the past 10 years.

Authors:  I Greaves; A J Grant; D A Heath; J Michael; D Adu
Journal:  BMJ       Date:  1992-05-16

2.  Relationship between physicochemical and osteotropic properties of bisphosphonic derivatives: rational design for osteotropic drug delivery system (ODDS).

Authors:  H Hirabayashi; T Sawamoto; J Fujisaki; Y Tokunaga; S Kimura; T Hata
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

Review 3.  Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.

Authors:  Hideki Hirabayashi; Jiro Fujisaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders.

Authors:  Lei Dang; Jin Liu; Fangfei Li; Luyao Wang; Defang Li; Baosheng Guo; Xiaojuan He; Feng Jiang; Chao Liang; Biao Liu; Shaikh Atik Badshah; Bing He; Jun Lu; Cheng Lu; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.